SynthesisRMD open2023

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials.

Agathe Denis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.